On April 1st, the "Working Together to Build a New Great Wall of Diagnosis and Treatment - New Progress Training Course on Pain Disease Diagnosis and Treatment" was held in Xi'an. This conference is hosted by China Health Science and Education Audiovisual Publishing House, with public welfare support from Kunming Beck Norton Company, a subsidiary of Kunming Pharmaceutical Group. The conference is held through a combination of online and offline methods. The aim of this conference is to unite experts and scholars from various disciplines, expand the team of clinical doctors in related fields, innovate academic theories, improve diagnosis and treatment technologies, strengthen the promotion of diagnosis and treatment standards, promote reform in the pharmaceutical field, and improve the service level of medical institutions, Promote rational medication, better safeguard people's health, and better serve the public. Zhang Xiaoyue, Training Department of China Health Education Center, delivered a speech at the conference. He emphasized that the fundamental purpose of building a healthy China is national health, and the meaning of national health is that each of us should strive to achieve the ideal state of health at different stages of life. This requires us to focus on the entire population and the entire life cycle, provide fair, accessible, systematic and continuous health services for everyone, and achieve a higher level of national health concept. Xu Peng, Vice President of Xi'an Honghui Hospital, served as the President of the conference and delivered an important speech. He stated that this public welfare activity is aimed at experts from pain departments, orthopedics, rheumatism departments, and other related departments in second and third level hospitals across the country, providing training and learning on new progress and new ideas in the diagnosis and treatment of pain diseases. Wu Xiaojun, Vice President of Marketing Company of Kunyao Group, also delivered a speech at the conference. He stated that Kunyao Group is working to solve pain related diseases and difficult pain problems encountered in clinical medicine, adhering to innovation as its corporate DNA, relying on natural plant resources in Yunnan, and continuously exploring and exploring the field of pain diagnosis and treatment drug research and development, creating a product that can be widely used in rheumatic immune diseases, osteoarthritis The drug for the treatment of cancer pain and other chronic pain diseases - Caowu Su A capsule, is a "good helper" for clinical doctors to solve related chronic pain diseases. Professor Liu Xianguo, Director of the Pain Research Center at Sun Yat sen University, introduced the latest research progress on neuropathic pain at home and abroad during the training process, starting from the mechanism of action of ionophores. Professor Lv Yan from the Pain Department of Xijing Hospital of Air Force Military Medical University subsequently received a specialized training on the progress of evidence-based medicine in the interventional treatment of herpes zoster neuralgia (PHN). He analyzed the difficulties in clinical treatment of PHN through case by case analysis and led the students to review relevant diagnostic and treatment methods and guidelines at home and abroad. Dong Bo, Deputy Director of the Pain Ward of the Rehabilitation Hospital of Xi'an Honghui Hospital, led the students to understand the development direction of traditional Chinese medicine orthopedics and traumatology and his understanding of pain treatment as a traditional Chinese medicine orthopedic doctor through a brief introduction and case analysis of the bowstring mechanical anatomy system and mesh theory. Wang Zhiyuan, Deputy Chief Physician of the Knee Joint Disease Department of Xi'an Honghui Hospital Joint Disease Hospital, brought training on TKA perioperative accelerated rehabilitation. He emphasized from the perspective of TKA surgery accelerated rehabilitation that chronic pain can easily cause pain sensitization, making the progress and recovery of pain diseases difficult to achieve as expected. Therefore, the treatment of chronic pain and central sensitization of patients is particularly important. At the beginning of this year, Kunyao Group